查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701393

人体类器官市场规模、份额、趋势分析报告：按产品、来源、器官类型、应用、最终用途、地区、细分市场预测，2025-2030 年

Human Organoids Market Size, Share & Trends Analysis Report By Product (Media & Supplements, Reagents, Organoid Models), By Sources, By Organ Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

人体类器官市场的成长与趋势：

根据 Grand View Research, Inc. 的新报告，全球人类类器官市场规模预计到 2030 年将达到 27.2 亿美元，2025 年至 2030 年的复合年增长率为 22.8%。

在干细胞研究和 3D 细胞培养技术的进步推动下，市场正在经历显着成长。

市场的主要驱动力之一是对个人化医疗日益增长的需求。来自患者特异性干细胞的类器官为研究个别疾病机制和测试客製化治疗方法提供了独特的平台。这种能力在肿瘤学中尤其有价值，因为肿瘤衍生的类器官可用于预测患者对化疗和标靶治疗的反应。随着医疗保健转向个人化治疗策略，基于类器官的模型的采用预计将增加，进一步推动市场成长。

此外，癌症、神经退化性疾病和肝病等慢性疾病的盛行率不断上升也是推动市场扩张的主要因素。类器官为研究这些病理提供了先进的模型，从而更深入地了解疾病机制并开发新的治疗性介入。例如，脑类器官被用于研究阿兹海默症和帕金森氏症等神经系统疾病，而肝臟和肾臟类器官则有助于开发器官衰竭的治疗方法。

儘管存在这些积极的趋势，但诸如伦理问题、监管障碍以及与类器官开发相关的高成本等挑战可能会带来一些限制。然而，正在进行的研究努力和技术进步有望解决这些挑战，并为类器官在生物医学和临床应用中的广泛应用铺平道路。

人体类器官市场报告重点

  • 根据产品，类器官模型部分在 2024 年占据了市场主导地位。这一巨大份额归因于药物发现、疾病建模和再生医学的日益普及。
  • 根据器官类型，肝臟部分将在 2024 年占据市场主导地位。其在药物代谢和毒性测试中的重要作用占有很大份额。
  • 根据消息来源，成体干细胞部分将在 2024 年引领人类类器官市场。
  • 根据应用，发育生物学在 2024 年主导了人类类器官市场。这一巨大份额是由于它们在理解细胞过程、组织工程和类器官发育方面发挥重要作用。
  • 根据最终用途，由于类器官技术在药物发现、临床前试验和个人化医疗的应用日益广泛，因此预计製药和生物技术公司将在 2024 年占据最大的市场占有率。
  • 2024 年，北美将引领人类类器官市场。这是由于对生物技术、先进医疗保健基础设施的大力投资，以及类器官技术在药物发现和个人化医疗中的日益普及。

目录

第一章调查方法与范围

第二章执行摘要

第三章 人体类器官市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人类类器官市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 人体类器官市场：依产品分類的预测与趋势分析

  • 产品细分仪表板
  • 全球人体类器官市场（按产品）波动分析
  • 全球人类类器官市场规模及趋势分析（依产品，2018-2030）
  • 媒体和补充资料
  • 试剂
  • 类器官模型

第五章 人体类器官市场：依供应来源估算及趋势分析

  • 源细分仪表板
  • 全球人体类器官市场的波动
  • 全球人体类器官市场规模及趋势分析（依来源）（2018-2030）
  • 成体干细胞
  • 诱导多功能细胞
  • 胚胎干细胞
  • 其他资讯来源

第六章 人体类器官市场：依器官类型分類的估价与趋势

  • 器官类型细分仪表板
  • 全球人体类器官市场：器官类型变异分析
  • 全球人体类器官市场规模及趋势分析（依器官类型，2018-2030）
  • 胃模型
  • 肠道模型
  • 肝臟模型
  • 胰臟模型
  • 肺模型
  • 大脑模型
  • 肾臟模型
  • 其他型号

第七章 人体类器官市场：依应用进行评估与趋势分析

  • 应用程式细分仪表板
  • 全球人体类器官市场趋势分析（依应用）
  • 全球人类类器官市场规模及趋势分析（依应用，2018-2030）
  • 发育生物学
  • 药物毒性和疗效研究
  • 疾病的病理学
  • 个人化医疗
  • 再生医学

第八章 人体类器官市场：依最终用途的估算与趋势分析

  • 最终用途细分仪表板
  • 全球人体类器官市场依最终用途变化分析
  • 2018-2030年全球人体类器官市场规模及趋势分析（依最终用途）
  • 製药和生物技术公司
  • CRO 和 CMO
  • 学术研究所
  • 其他用途

第九章 人体类器官市场：按产品、器官类型、来源、应用和最终用途分類的区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018年至2030年市场规模与预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/列表
    • ATCC
    • Thermo Fisher Scientific Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Corning Incorporated
    • Bio-Techne.
    • ACROBiosystems.
    • .AMSBIO
    • Qkine Ltd.
    • PRIMACYT Cell Culture Technology GmbH
Product Code: GVR-4-68040-540-7

Human Organoids Market Growth & Trends:

The global human organoids market size is anticipated to reach USD 2.72 billion by 2030 and is projected to grow at a CAGR of 22.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by advancements in stem cell research and 3D cell culture technologies.

One of the key drivers of the market is the rising demand for personalized medicine. Organoids derived from patient-specific stem cells offer a unique platform for studying individual disease mechanisms and testing tailored treatment approaches. This capability is particularly valuable in oncology, where tumor-derived organoids can be used to predict patient responses to chemotherapy or targeted therapies. As healthcare shifts towards personalized treatment strategies, the adoption of organoid-based models is expected to increase, further fueling market growth.

Moreover, the growing prevalence of chronic diseases, such as cancer, neurodegenerative disorders, and liver diseases, is another major factor driving market expansion. Organoids provide an advanced model to study these conditions, leading to a deeper understanding of disease mechanisms and the development of novel therapeutic interventions. For instance, brain organoids are being used to study neurological conditions like Alzheimer's and Parkinson's disease, while liver and kidney organoids are helping researchers develop treatments for organ failure.

Despite these positive trends, challenges such as ethical concerns, regulatory hurdles, and high costs associated with organoid development may pose limitations to some extent. However, ongoing research efforts and technological advancements are expected to address these challenges, paving the way for the broader adoption of organoids in biomedical and clinical applications.

Human Organoids Market Report Highlights:

  • Based on product, the organoid models segment dominated the market in 2024. The large share is driven by increasing drug discovery, disease modeling, and regenerative medicine adoption.
  • Based on organ type, the liver segment dominated the market in 2024. The large share is driven by its critical role in drug metabolism and toxicity testing.
  • Based on source, the adult stem cells segment led the human organoids market in 2024, driven by their widespread use in disease modeling, drug discovery, and regenerative medicine.
  • Based on application, developmental biology dominated the human organoids market in 2024. The large share is driven by its critical role in understanding cellular processes, tissue engineering, and organoid development.
  • Based on end use, the pharmaceutical & biotechnology companies held the largest market share in 2024, driven by the increasing adoption of organoid technology in drug discovery, preclinical testing, and personalized medicine.
  • In 2024, North America led the human organoids market, driven by strong investments in biotechnology, advanced healthcare infrastructure, and increasing adoption of organoid technology in drug discovery and personalized medicine.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Organ Type
    • 1.2.3. Source
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Human Organoids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising research on gut-related diseases
      • 3.2.1.2. Advancements in microbiome studies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High development costs
  • 3.3. Human Organoids Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Organoids Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Human Organoids Market Product Movement Analysis
  • 4.3. Global Human Organoids Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Media & Supplements
    • 4.4.1. Media & supplements market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Organoid Models
    • 4.6.1. Organoid Models market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Organoids Market: Source Estimates & Trend Analysis

  • 5.1. Source Segment Dashboard
  • 5.2. Global Human Organoids Market Source Movement Analysis
  • 5.3. Global Human Organoids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
  • 5.4. Adult Stem Cells
    • 5.4.1. Adult stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Induced Pluripotent Stem Cells
    • 5.5.1. Induced pluripotent stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Embryonic Stem Cells
    • 5.6.1. Embryonic stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Other Sources
    • 5.7.1. Other sources market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Organoids Market: Organ Type Estimates & Trend Analysis

  • 6.1. Organ Type Segment Dashboard
  • 6.2. Global Human Organoids Market Organ Type Movement Analysis
  • 6.3. Global Human Organoids Market Size & Trend Analysis, by Organ Type, 2018 to 2030 (USD Million)
  • 6.4. Stomach Models
    • 6.4.1. Stomach models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Intestine Models
    • 6.5.1. Intestine models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Liver Models
    • 6.6.1. Liver models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Pancreatic Models
    • 6.7.1. Pancreatic models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Lung Models
    • 6.8.1. Lung models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Brain Models
    • 6.9.1. Brain models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Kidney Models
    • 6.10.1. Kidney models market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.11. Other Models
    • 6.11.1. Other models market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Organoids Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Human Organoids Market Application Movement Analysis
  • 7.3. Global Human Organoids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Developmental Biology
    • 7.4.1. Developmental biology market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Drug Toxicity & Efficacy Testing
    • 7.5.1. Drug toxicity & efficacy testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Disease Pathology
    • 7.6.1. Disease pathology market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Personalized Medicine
    • 7.7.1. Personalized medicine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Regenerative Medicine
    • 7.8.1. Regenerative medicine market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Human Organoids Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Human Organoids Market End Use Movement Analysis
  • 8.3. Global Human Organoids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. CROs & CMOs
    • 8.5.1. CROs & CMOs market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Academic & Research Institutes
    • 8.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Other End Use
    • 8.7.1. Other end use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Human Organoids Market: Regional Estimates & Trend Analysis by Product, Organ Type, Source, Application, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Regulatory framework
      • 9.8.5.3. Competitive scenario
      • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. ATCC
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. STEMCELL Technologies
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Merck KGaA
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Corning Incorporated
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Bio-Techne.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. ACROBiosystems.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. .AMSBIO
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Qkine Ltd.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. PRIMACYT Cell Culture Technology GmbH
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global human organoids market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 5 Global human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 6 Global human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 11 North America human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 12 North America human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 16 U.S. human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 17 U.S. human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 20 Canada human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 21 Canada human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 22 Canada human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 26 Mexico human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 27 Mexico human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 31 Europe human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 32 Europe human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 33 Europe human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 36 Germany human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 37 Germany human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 38 Germany human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 39 Germany human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 41 UK human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 42 UK human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 43 UK human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 44 UK human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 46 France human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 47 France human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 48 France human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 49 France human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 51 Italy human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 52 Italy human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 53 Italy human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 56 Spain human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 57 Spain human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 58 Spain human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 61 Denmark human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 62 Denmark human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 63 Denmark human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 66 Sweden human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 67 Sweden human organoids market, by sources, 2018 - 2030 (USD Million
  • Table 68 Sweden human organoids market, by application, 2018 - 2030 (USD Million
  • Table 69 Sweden human organoids market, by end use, 2018 - 2030 (USD Million
  • Table 70 Norway human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 72 Norway human organoids market, by sources, 2018 - 2030 (USD Million
  • Table 73 Norway human organoids market, by application, 2018 - 2030 (USD Million
  • Table 74 Norway human organoids market, by end use, 2018 - 2030 (USD Million
  • Table 75 Asia Pacific human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific human organoids market, by sources, 2018 - 2030 (USD Million
  • Table 78 Asia Pacific human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific human organoids market, by application, 2018 - 2030 (USD Million
  • Table 80 Asia Pacific human organoids market, by end use, 2018 - 2030 (USD Million
  • Table 81 China human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 82 China human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 83 China human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 84 China human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 85 China human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 87 Japan human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 88 Japan human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 89 Japan human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 90 Japan human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 92 India human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 93 India human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 94 India human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 95 India human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 97 South Korea human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 98 South Korea human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 99 South Korea human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 100 South Korea human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 102 Australia human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 103 Australia human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 104 Australia human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 105 Australia human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 107 Thailand human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 108 Thailand human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 109 Thailand human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 110 Thailand human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 113 Latin America human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 114 Latin America human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 115 Latin America human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 118 Brazil human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 119 Brazil human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 120 Brazil human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 123 Argentina human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 124 Argentina human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 125 Argentina human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA human organoids market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 129 MEA human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 130 MEA human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 131 MEA human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 134 South Africa human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 135 South Africa human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 136 South Africa human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 144 UAE human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 145 UAE human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 146 UAE human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE human organoids market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait human organoids market, by product, 2018 - 2030 (USD Million)
  • Table 149 Kuwait human organoids market, by organ type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait human organoids market, by sources, 2018 - 2030 (USD Million)
  • Table 151 Kuwait human organoids market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait human organoids market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Human organoids market: Market outlook
  • Fig. 5 Human organoids market: Segment outlook
  • Fig. 6 Human organoids market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Human organoids market driver impact
  • Fig. 9 Human organoids market restraint impact
  • Fig. 10 Human organoids market: Product outlook and key takeaways
  • Fig. 11 Human organoids market: Product movement analysis
  • Fig. 12 Media & supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Organoid Models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Human organoids market: Source outlook and key takeaways
  • Fig. 16 Human organoids market: Source movement analysis
  • Fig. 17 Adult stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Induced pluripotent stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Embryonic stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Other sources market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Human organoids market: Organ type outlook and key takeaways
  • Fig. 22 Human organoids market: Organ type movement analysis
  • Fig. 23 Stomach models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Intestine models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Liver models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Pancreatic models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Lung models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Brain models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Kidney models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other models market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Human organoids market: Application outlook and key takeaways
  • Fig. 32 Human organoids market: Application movement analysis
  • Fig. 33 Developmental biology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 35 Disease pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Personalized medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Regenerative medicine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Human organoids market: End use outlook and key takeaways
  • Fig. 39 Human organoids market: End use movement analysis
  • Fig. 40 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 CROs & CMOs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 42 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 43 Other end use market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 44 Global human organoids market: Regional outlook and key takeaways
  • Fig. 45 Global human organoids market: Regional movement analysis
  • Fig. 46 North America human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Europe human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Germany human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Japan human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait human organoids market estimates and forecasts, 2018 - 2030 (USD Million)